SCHEMBL28464173

SCHEMBL28464173

CN(CCC1CCCN1C(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.36
▸ ATM Q13315 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ POLB P06746 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTR2C P28335 4/20 0.32
▸ SLC6A4 P31645 4/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ RIPK1 Q13546 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16528528 0.86 HSD17B10 (0.38) HSD17B10SMN1; SMN2POLBL3MBTL1LMNA
SCHEMBL25193443 0.86 HSD17B10 (0.38) HSD17B10SMN1; SMN2POLBL3MBTL1LMNA
SCHEMBL31296240 0.86 HSD17B10 (0.38) HSD17B10SMN1; SMN2POLBL3MBTL1LMNA
SCHEMBL28473523 0.79 POLB (0.38) POLBL3MBTL1KCNH2HRH3
SCHEMBL34473181 0.77 HSD17B10 (0.47) HSD17B10ATMSMN1; SMN2ALDH1A1
SCHEMBL21996681 0.77 GPR119 (0.41) —
SCHEMBL25180826 0.76 SIGMAR1 (0.49) —
SCHEMBL30511049 0.76 KLK7 (0.47) ATM
SCHEMBL27374399 0.75 HTR2C (0.37) HTR2CSLC6A4ALDH1A1HTR2A
SCHEMBL29286314 0.73 CA14 (0.35) HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111801100-B 7-substituted sulfoimidoyl purinone compounds and derivatives for the treatment and prevention of liver cancer 豪夫迈·罗氏有限公司 2023-10-24 — — CN disclosed
CN-111801100-A 7-substituted sulfoxy-purinone compounds and derivatives for the treatment and prevention of liver cancer 豪夫迈·罗氏有限公司 2020-10-20 — — CN disclosed
Send feedback